EU's looming API certification deadline causing angst; FDA says most Indian drugmakers are doing well;

> An auditing firm is warning European drugmakers that some Chinese API makers will not be inspected and certified before next month's deadline for new EU rules on imported APIs. Story

> Some drugmakers in Turkey are complaining that the EU's process for getting drugs approved takes too long. Story

> A new report forecasts world demand for pharmaceutical packaging products to grow 6.4% annually, hitting $90 billion in 2017. More

> The Ash Stevens plant in Riverview, MI, has been approved by the FDA to manufacture the API in ARIAD Pharmaceuticals' ($ARIA) recently approved oncology drug Iclusig. Item

And Finally... A spokesman for the FDA tells an Indian newspaper that India's share of the drug market is a good indication that, some problems aside, many drugmakers there are following the FDA's stringent quality standards. Story